EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a novel neuronal phenotypic in vitro model of familial Alzheimer's disease using the human neuroblastoma-derived immortalized SH-SY5Y cell line

Mateo Barro, Antón L. Martínez, David Moreira, Neila Cosme, Magdalena Asensio, José Brea, María Isabel Loza

Journal of Alzheimer’s Disease · 19.11.2026

DOI: 10.1177/13872877261506370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 19.11.2026. Verfasst von Mateo Barro und 6 weiteren Autor:innen. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Xunta de Galicia, Ministerio de Ciencia, Innovación y Universidades.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the leading cause of dementia. Despite its undeniable effect on current society, it remains one of the diseases for which clinical trials have the highest failure rate, and therapeutic interventions remain palliative, thus creating an unmet demand to develop translational models that can accelerate pre-clinical drug discovery.

Objective

We aimed to develop a scalable neuronal phenotypic model using differentiated SH-SY5Y cells with mature neuronal phenotypes.

Methods

SH-SY5Y were differentiated by exposure to either retinoic acid and phorbol 12-myristate 13-acetate or retinoic acid and GLP-1. Cells differentiated with retinoic acid and GLP-1 were transfected with APP V717I and MAPT P301L mutants. Mutation-induced morphological alterations were measured by immunocytochemistry and neuron activation through intracellular calcium accumulation.

Results

Transfection induced alterations, including reduced cell densities, neurite lengths, and dendritic arborization, together with increase of amyloid-β (Aβ) aggregation and ROS activity, which are compatible with the neurodegenerative changes observed in AD. A physiological assay based on intracellular calcium imaging revealed hypoexcitability in transfected cultures, suggesting a neurodegenerative process compatible with the later stages of the disease. Treatment of cell cultures with the reference neuroprotective compounds melatonin and resveratrol exerted a significant restorative effect on the morphophysiological variables studied.

Conclusions

Therefore, we introduce a novel, miniaturized, and automatable in vitro AD model that enables studies on the neurodegenerative mechanisms related to the disease and supports high-throughput screening assays for pre-clinical drug discovery.

Förderung

  • Agencia Estatal de Investigación
  • Xunta de Galicia
  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Barro, M., Martínez, A. L., Moreira, D., Cosme, N., Asensio, M., Brea, J., & Loza, M. I. (2026). Development of a novel neuronal phenotypic in vitro model of familial Alzheimer's disease using the human neuroblastoma-derived immortalized SH-SY5Y cell line. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261506370

Vancouver

Barro M, Martínez AL, Moreira D, Cosme N, Asensio M, Brea J, et al. Development of a novel neuronal phenotypic in vitro model of familial Alzheimer's disease using the human neuroblastoma-derived immortalized SH-SY5Y cell line. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261506370

BibTeX
@article{Barro2026,
  author = {Barro, Mateo and Martínez, Antón L. and Moreira, David and Cosme, Neila and Asensio, Magdalena and Brea, José and Loza, María Isabel},
  title = {Development of a novel neuronal phenotypic in vitro model of familial Alzheimer's disease using the human neuroblastoma-derived immortalized SH-SY5Y cell line},
  journal = {Journal of Alzheimer’s Disease},
  year = {2026},
  doi = {10.1177/13872877261506370}
}
Kostenlos starten →